The transition from generalized medicine to highly individualized, gene-based therapy has triggered an unprecedented expansion in genetic analysis. Valued at US$ 30.5 Billion in 2023, the Global Genotyping Assays Market is projected to reach a massive US$ 285.3 Billion by 2034, expanding at an explosive CAGR of 22.5%. As of March 2026, the industry has entered...